Jens Hoeppner/klinikum-lippe.de
Feb 4, 2025, 08:25
Perioperative chemo (FLOT) outperforms preop chemoradiotherapy for resectable esophageal adenocarcinoma
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared an article by Jens Hoeppner, et al. on LinkedIn:
“Perioperative chemo (FLOT) outperforms preop chemoradiotherapy (CRT) for resectable esophageal adenocarcinoma!
- 3-year OS**: 57.4% (FLOT) vs. 50.7%
- Grade 3+ adverse events**: 58% (FLOT) vs. 50%
- 90-day mortality**: 3.1% (FLOT) vs. 5.6%
FLOT shows better survival outcomes! “
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.
Authors: Jens Hoeppner, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 4, 2025, 08:12
Feb 4, 2025, 08:00
Feb 3, 2025, 18:56
Feb 3, 2025, 18:53